Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg
Product details
Registration number: SIN14290P
Classification: Prescription Only
Active ingredients: Lanreotide Acetate 113.6mg eqv lanreotide
Strength: 90 mg
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: IPSEN PHARMA SINGAPORE PTE. LTD.
ATC code: H01C B03
HSA approval date: 16 January 2013
Manufacturer(s):
- IPSEN PHARMA BIOTECH
- IPSEN PHARMA BIOTECH, ETABLISSEMENT GAMMASTER - Gamma Irradiation
- STERIGENICS BELGIUM - Gamma Irradiation
Manufacturing country/countries: FRANCE; BELGIUM
What are the HSA registration number and classification for Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14290P
Classification: Prescription Only
What active ingredients and strength are recorded for Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Lanreotide Acetate 113.6mg eqv lanreotide
Strength: 90 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg?
According to the HSA dataset updated 7 August 2026:
Registrant: IPSEN PHARMA SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- IPSEN PHARMA BIOTECH
- IPSEN PHARMA BIOTECH, ETABLISSEMENT GAMMASTER - Gamma Irradiation
- STERIGENICS BELGIUM - Gamma Irradiation
Manufacturing country/countries: FRANCE; BELGIUM
Where can I look up Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14290P or the exact product name Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg. The general register link does not preselect this product.
What are the source dates for this Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14290P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)